In a HER2-driven mouse BC model, Hosseini and coworkers demonstrated that the cells from early lesions displayed enhanced stemness, migratory, and prometastatic features as compared to cells from advanced tumors and that an impressive 80% of metastases were derived from early disseminated cancer cells [160]. This evidence concerns the gene ERBB2 and breast cancer.